Merck and partner Ridgeback said on Tuesday they had withdrawn their COVID-19 pill application in the EU, months after the region’s regulator did not back the drug citing insufficient data.
Reuters Health Information Read More
Merck and partner Ridgeback said on Tuesday they had withdrawn their COVID-19 pill application in the EU, months after the region’s regulator did not back the drug citing insufficient data.
Reuters Health Information Read More